Leadership changes
Executive appointments and departures from SEC 8-K filings, updated within hours of each filing.
Updated Nov 6, 2026
Changes, November 2026
292
Appointments
143
Departures
34
Browse by role
Get new CFO appointments the day the filing lands.
Browse by month
Filters
3,420 changes
| Filing date | Company | Person | Role | Change | Effective date | Source |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | Korsana Biosciences, Inc. | Steven E. Hyman, M.D. | DirectorDirector | Departed | Sep 8, 2026 | SEC 8-K |
| Sep 11, 2026 | Korsana Biosciences, Inc. | Dina Katabi, Ph.D. | DirectorDirector | Departed | Sep 8, 2026 | SEC 8-K |
| Sep 11, 2026 | Korsana Biosciences, Inc. | Rhonda M. Chicko | Chief Financial OfficerCFO | Departed | Sep 8, 2026 | SEC 8-K |
| Sep 11, 2026 | Korsana Biosciences, Inc. | Jonathan Violin, Ph.D. | Chief Executive Officer and PresidentCEO | Appointed | Sep 8, 2026 | SEC 8-K |
| Sep 11, 2026 | Korsana Biosciences, Inc. | Mark Vignola, Ph.D. | Chief Financial OfficerCFO | Appointed | Sep 8, 2026 | SEC 8-K |
| Sep 11, 2026 | Korsana Biosciences, Inc. | Matthew Leoni, M.D. | Chief Medical OfficerCMO | Appointed | Sep 8, 2026 | SEC 8-K |
| Sep 11, 2026 | Korsana Biosciences, Inc. | Andrew Gottesdiener, M.D. | DirectorDirector | Appointed | Sep 8, 2026 | SEC 8-K |
| Sep 11, 2026 | Korsana Biosciences, Inc. | Heidi Henson | DirectorDirector | Appointed | Sep 8, 2026 | SEC 8-K |
| Sep 11, 2026 | Korsana Biosciences, Inc. | Tomas Kiselak | Chair of the BoardChair of the Board | Appointed | Sep 8, 2026 | SEC 8-K |
| Sep 11, 2026 | Korsana Biosciences, Inc. | Michelle Pernice | DirectorDirector | Appointed | Sep 8, 2026 | SEC 8-K |
| Sep 11, 2026 | Korsana Biosciences, Inc. | Nimish Shah | DirectorDirector | Appointed | Sep 8, 2026 | SEC 8-K |
| Sep 11, 2026 | LITHIUM AMERICAS CORP. | Alexi Zawadzki | Vice President, Corporate DevelopmentVice President, Corporate Development | Departed | Sep 11, 2026 | SEC 8-K |
| Sep 11, 2026 | Lucid Group, Inc. | Taoufiq Boussaid | Chief Financial OfficerCFO | Departed | n/a | SEC 8-K |
| Sep 11, 2026 | Ocean Capital Acquisition Corp | Man Kai (Anthony) Ho | Chief Financial OfficerCFO | Departed | Sep 9, 2026 | SEC 8-K |
| Sep 11, 2026 | Oportun Financial Corp | William Franklin | Chief Financial Officer and principal financial officerCFO | Appointed | Sep 8, 2026 | SEC 8-K |
| Sep 11, 2026 | Oportun Financial Corp | Joseph Schueller | principal financial officerCFO | Departed | Sep 8, 2026 | SEC 8-K |
| Sep 11, 2026 | Park Hotels & Resorts Inc. | Thomas C. Morey | Executive Vice President and Chief Investment OfficerCIO | Departed | Sep 8, 2026 | SEC 8-K |
| Sep 11, 2026 | Peraso Inc. | James Sullivan | Chief Financial Officer and SecretaryCFO | Departed | Oct 2, 2026 | SEC 8-K |
| Sep 11, 2026 | Peraso Inc. | Ronald Glibbery | Chief Financial Officer and SecretaryCFO | Appointed | Oct 2, 2026 | SEC 8-K |
| Sep 11, 2026 | Q/C TECHNOLOGIES, INC. | Chelsea Voss | member of the Company’s Board of Directorsmember of the Company’s Board of Directors | Departed | Sep 10, 2026 | SEC 8-K |
- Korsana Biosciences, Inc.Departed
Steven E. Hyman, M.D. Director
Filed Sep 11, 2026Effective Sep 8, 2026SEC 8-K
- Korsana Biosciences, Inc.Departed
Dina Katabi, Ph.D. Director
Filed Sep 11, 2026Effective Sep 8, 2026SEC 8-K
- Korsana Biosciences, Inc.Departed
Rhonda M. Chicko CFO
Filed Sep 11, 2026Effective Sep 8, 2026SEC 8-K
- Korsana Biosciences, Inc.Appointed
Jonathan Violin, Ph.D. CEO
Filed Sep 11, 2026Effective Sep 8, 2026SEC 8-K
- Korsana Biosciences, Inc.Appointed
Mark Vignola, Ph.D. CFO
Filed Sep 11, 2026Effective Sep 8, 2026SEC 8-K
- Korsana Biosciences, Inc.Appointed
Matthew Leoni, M.D. CMO
Filed Sep 11, 2026Effective Sep 8, 2026SEC 8-K
- Korsana Biosciences, Inc.Appointed
Andrew Gottesdiener, M.D. Director
Filed Sep 11, 2026Effective Sep 8, 2026SEC 8-K
- Korsana Biosciences, Inc.Appointed
Heidi Henson Director
Filed Sep 11, 2026Effective Sep 8, 2026SEC 8-K
- Korsana Biosciences, Inc.Appointed
Tomas Kiselak Chair of the Board
Filed Sep 11, 2026Effective Sep 8, 2026SEC 8-K
- Korsana Biosciences, Inc.Appointed
Michelle Pernice Director
Filed Sep 11, 2026Effective Sep 8, 2026SEC 8-K
- Korsana Biosciences, Inc.Appointed
Nimish Shah Director
Filed Sep 11, 2026Effective Sep 8, 2026SEC 8-K
- LITHIUM AMERICAS CORP.Departed
Alexi Zawadzki Vice President, Corporate Development
Filed Sep 11, 2026Effective Sep 11, 2026SEC 8-K
- Lucid Group, Inc.Departed
Taoufiq Boussaid CFO
Filed Sep 11, 2026SEC 8-K
- Ocean Capital Acquisition CorpDeparted
Man Kai (Anthony) Ho CFO
Filed Sep 11, 2026Effective Sep 9, 2026SEC 8-K
- Oportun Financial CorpAppointed
William Franklin CFO
Filed Sep 11, 2026Effective Sep 8, 2026SEC 8-K
- Oportun Financial CorpDeparted
Joseph Schueller CFO
Filed Sep 11, 2026Effective Sep 8, 2026SEC 8-K
- Park Hotels & Resorts Inc.Departed
Thomas C. Morey CIO
Filed Sep 11, 2026Effective Sep 8, 2026SEC 8-K
- Peraso Inc.Departed
James Sullivan CFO
Filed Sep 11, 2026Effective Oct 2, 2026SEC 8-K
- Peraso Inc.Appointed
Ronald Glibbery CFO
Filed Sep 11, 2026Effective Oct 2, 2026SEC 8-K
- Q/C TECHNOLOGIES, INC.Departed
Chelsea Voss member of the Company’s Board of Directors
Filed Sep 11, 2026Effective Sep 10, 2026SEC 8-K